Market Overview

UPDATE: JP Morgan Initiates Neutral, $24 PT on Molina Healthcare on Headwinds from Medical Costs

Share:
Related MOH
Sterne Agee: Tough Flu Season Helps Hospitals, Hurts Insurers
Top 4 NYSE Stocks In The Health Care Plans Industry With The Highest EPS Growth Forecast For Next 5 Years

JP Morgan initiates Molina Healthcare (NYSE: MOH) with a Neutral rating and a price target of $24.

JP Morgan comments, "While its position as the fifth largest Medicaid player leaves it as one of the more compelling top-line growth stories particularly given its exposure to the near-term Dual Eligible opportunity, Molina's earnings trajectory is much less clear given the headwinds from higher than expected medical costs in Texas and as well as the pace and potential of the earnings contribution from the Duals. Look for key upcoming catalysts to be visible on Texas rates and the imminent Supreme Court decision on healthcare reform."

MOH closed at $22.28 on Tuesday.

Latest Ratings for MOH

DateFirmActionFromTo
Jan 2015BarclaysMaintainsEqual-weight
Jan 2015Deutsche BankMaintainsHold
Nov 2014Bank of AmericaMaintainsBuy

View More Analyst Ratings for MOH
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Initiation Intraday Update Analyst Ratings

 

Related Articles (MOH)

Around the Web, We're Loving...

Get Benzinga's Newsletters